星湖科技(600866.SH):擬購買伊品生物99.22%股權 將進一步豐富公司食品添加劑等產品種類、明起復牌
格隆匯3月21日丨星湖科技(600866.SH)公佈發行股份及支付現金購買資產並募集配套資金暨關聯交易預案,上市公司擬通過發行股份及支付現金的方式購買伊品生物99.22%股權,此次交易完成後,伊品生物將成為上市公司的控股子公司。
此次交易前,廣新集團持有上市公司權益的股份合計149,422,420股,持股比例為20.22%,繫上市公司控股股東。此次重組前36個月內,廣新集團始終為公司的控股股東,廣東省人民政府始終為上市公司的實際控制人。此次交易完成後,預計廣新集團仍為上市公司持股比例最大的股東和控股股東。廣東省人民政府仍為上市公司的實際控制人。
此次交易前,上市公司主要從事食品添加劑、醫藥中間體、生化原料藥及製劑和飼料添加劑的研發、生產和銷售,產品應用範圍涵蓋食品加工、飼料加工、醫藥製造等多個領域,目前公司主導產品為以玉米澱粉為原材料通過生物發酵工藝製成的食品添加劑、化學原料藥及醫藥中間體。標的公司主要從事玉米深加工行業,主要產品為動物營養氨基酸、食品添加劑、增鮮類調味品及復混肥等。
此次交易完成後,伊品生物將成為上市公司的控股子公司。上市公司食品添加劑、飼料添加劑產品種類將進一步豐富,業務規模將進一步提升,雙方均可延伸其原有的產業鏈,實現縱向一體化,發揮業務之間的協同效應,提高上市公司的經營效率和經營成果。
此外,根據相關規定,經向上海證券交易所申請,公司股票將於2022年3月22日(星期二)開市起復牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.